Alice Park

Alice Park is a staff writer at TIME. She has reported on the breaking frontiers of health and medicine in articles covering issues such as AIDS, anxiety and Alzheimer's disease. Her latest book is The Stem Cell Hope: How Stem Cell Medicine Can Change Our Lives.

Recent Articles

FDA Approves New RSV Vaccine for Older Adults

Pfizer's new shot for seniors becomes the second RSV vaccine in the world.

By Alice Park

U.S. Surgeon General: Social Media Can Harm Kids

Dr. Vivek Murthy tells TIME why he's worried about social media's threat to the mental health of kids and teens.

By Alice Park

Multivitamins May Improve Memory, Study Shows

Taking a daily multivitamin can improve memory and slow some of the cognitive decline associated with aging, new research shows.

By Alice Park

U.S. HIV Rates Are Declining

The CDC documents an encouraging drop in HIV among young people, but disparities in accessing treatments persist.

By Alice Park

The Next COVID-19 Vaccine Should Only Target XBB: WHO

U.S. health officials will consider the advice when they select strains for the next COVID-19 shot.

By Alice Park

Mammogram Guidelines Are Changing

Here’s the latest mammogram screening advice from a U.S. government task force, and why the group revised its guidelines.

By Alice Park

The COVID-19 Public Health Emergency Is Over

The emergency may be over, but there are valuable lessons to be learned from what went right.

By Alice Park

FDA Panel Recommends First Over-the-Counter Birth Control Pill

The recommendation comes at a fraught time for reproductive rights.

By Alice Park

What Will Happen When the U.S. Stops Tracking COVID-19 Data Like it Used To

When the COVID-19 public health emergency ends on May 11, CDC will stop providing daily COVID-19 data. Here’s what will replace the old system.

By Alice Park

COVID-19 Vaccines Aren't Strongly Linked to Menstrual Changes

The study is among the first to look at more severe bleeding events and changes in menstrual cycles after COVID-19 vaccination.

By Alice Park

Why It Took So Long to Get an RSV Vaccine

After years of failures, the first vaccine was approved, and more are coming.

By Alice Park

Eli Lilly's Alzheimer's Drug Shows Greatest Benefit Yet

Donanemab slowed cognitive decline in people with early Alzheimer’s disease by 35%, according to the company.

By Alice Park

Here's How Long COVID-19 Vaccine Immunity Really Lasts

A study quantifies how much vaccine protection drops over time and makes a case for boosters.

By Alice Park

FDA Approves First Pill for the Microbiome

The therapy opens the door to future treatments that may restore healthy bacteria in the body.

By Alice Park

What May Be Next for the Other Abortion Pill

States are stockpiling misoprostol, but its legal fate could be uncertain as well.

By Alice Park

What the CDC's New COVID-19 Vaccine Recommendations Mean for You

The advice will hold until health officials make final decisions on a potential yearly COVID-19 vaccine shot for most people.

By Alice Park

Democratic States Are Stockpiling Abortion Pills

While mifepristone's legal status is worked out in the courts, some states are taking steps to maintain access.

By Alice Park

The FDA Commissioner Who Approved the Abortion Pill Is Still Fighting for It

A Q&A with Dr. Jane Henney, who led the FDA when mifepristone was approved.

By Alice Park

What the New Abortion Pill Restrictions Mean—and What Comes Next

An appeals court decision put a hold on a judge’s ruling to remove mifepristone's approval. But it also issued new restrictions.

By Alice Park

Suicide Rates Rose in 2021 After a Pandemic-Era Drop

Young people were especially affected.

By Alice Park
More from TIME
More From TIME